These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6694528)

  • 1. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Oblin A; Fage D; Scatton B
    Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN
    Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN
    Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclo(Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine: agonist binding to D2 dopamine receptors correlates with stereotypic behavior.
    Lee JM; Fields JZ; Ritzmann RF
    Life Sci; 1983; 33 Suppl 1():405-8. PubMed ID: 6229678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypophysectomy fails to affect the supersensitivity of striatal dopamine target cells induced by prolonged haloperidol treatment.
    Scatton B; Fage D
    Eur J Pharmacol; 1984 Feb; 98(1):1-7. PubMed ID: 6538845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of neuroleptic-induced dopamine receptor supersensitivity by cyclo (Leu-Gly).
    Bhargava HN; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Nov; 13(5):633-6. PubMed ID: 7443732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF
    Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide inhibition of morphine-induced dopaminergic supersensitivity.
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 Nov 15-22; 31(20-21):2287-90. PubMed ID: 6891737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
    Bhargava HN
    Neuropharmacology; 1983 Dec; 22(12A):1357-61. PubMed ID: 6141535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclo (Leu-Gly) + haloperidol: effects on dopamine receptors and conditioned avoidance responding.
    Bean AJ; Elgin RJ; Cooper DM; Martin GE
    Peptides; 1987; 8(1):39-44. PubMed ID: 3575153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

  • 16. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
    Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclo(Leu-Gly) on the supersensitivity of dopamine receptors in spontaneously hypertensive rats.
    Bhargava HN
    Life Sci; 1983 May; 32(18):2131-7. PubMed ID: 6843287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract]   [Full Text] [Related]  

  • 20. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Rajakumar G; Naas F; Johnson RL; Chiu S; Yu KL; Mishra RK
    Peptides; 1987; 8(5):855-61. PubMed ID: 2893360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.